BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Drug Development

  Boston’s Intarcia Pink Slips 60 Employees, Terminates Two Late-Stage Trials

  A tipster told BioSpace that the layoffs were initially announced by Intarcia CEO Kurt Graves on Jan. 31.

  February 5, 2018

   · 

  3 min read

   · 

  Alex Keown
• Business

  AbSci Appoints Alan Herman, PhD to Scientific Advisory Board

  AbSci, announced the addition of Coherus’ CSO, Alan Herman, PhD to its Scientific Advisory Board.

  February 5, 2018

   · 

  2 min read
• Biotech Bay

  Abcam and Molecular Devices Announce Strategic Collaboration

  Abcam today announced a strategic collaboration to develop a wide range of fast and reproducible screening tools for researchers.

  February 5, 2018

   · 

  2 min read
• Biotech Beach

  J&J Vision Announces Publication of Two Studies in Clinical Ophthalmology Demonstrating Effectiveness of LipiFlow as Treatment of the Leading Cause of Dry Eye Disease

  In the first study1, a single LipiFlow treatment significantly improved mean meibomian gland function and significantly reduced mean dry eye signs and symptoms from baseline to three months for soft contact lens wearers with MGD, compared to those in an untreated control arm.

  February 5, 2018

   · 

  7 min read
• Biotech Bay

  Genomic Health Release: Oncotype DX Genomic Prostate Score Test Increases Use of Active Surveillance by 30 Percent in Low-Risk Patients, Resulting in Greater Adherence to Guideline-Based Care

  Results of this large, independently conducted study, published in Reviews in Urology, bring the collective published clinical utility evidence to four studies in nearly 8,300 men, demonstrating the actionable impact of the GPS test in treatment planning.

  February 5, 2018

   · 

  4 min read
• 

  Deals

  Varian Snaps Up Privately-Held Mobius Medical Systems

  The deal expands the company’s Quality Assurance tool portfolio.

  February 5, 2018

   · 

  2 min read
• Business

  FLX Bio Adds Distinguished Biopharma Industry Leader Michael Giordano, M.D., to Board of Directors

  FLX Bio today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.

  February 5, 2018

   · 

  3 min read
• Business

  InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and CEO

  Dr. Toselli also has been appointed to the company’s Board of Directors and will continue to serve in his capacity as InVivo’s Chief Medical Officer, which role he assumed upon joining the company in July 2017.

  February 5, 2018

   · 

  5 min read
• Lone Star Bio

  True Health Launches Comprehensive Celiac Disease & Gluten Sensitivity Testing

  Today, True Health announced that it is now offering comprehensive testing for celiac disease and gluten sensitivity.

  February 5, 2018

   · 

  2 min read
• Tru-D’s New Study Details Implementation Process for BETR-D Randomized Clinical Trial on UVC Disinfection

  A recent paper has been published detailing the implementation process of the BETR-D study, the first and only randomized clinical trial on UVC disinfection.

  February 5, 2018

   · 

  3 min read